Carnot involved : AP HP*, OPALE*, CALYM, CEA LETI, Chimie Balard Cirimat, Curie Cancer, I2C, Brain Institute, Imagine et Voir & Entendre
*participants to ITD
The Carnot network for Advanced Therapy Medicinal Products (ATMPs) offers industry agile access to unique advice and solutions to accelerate the R&D of biotherapy innovations. Carnot AP-HP, CALYM, CEA LETI, Chimie Balard Cirimat, Curie Cancer, I2C, Institut du Cerveau, Imagine, OPALE and Voir & Entendre cover the full range of biomedical expertise and mastery of the processes and technologies needed to develop cutting-edge biomedicines, biomaterials and devices in various therapeutic fields. We support our partners across the entire R&D value chain: formulation and synthesis, new therapeutic targets, preclinical validation, imaging, biomarkers, clinical validation, real-life monitoring, bioproduction, biotesting.
